172 related articles for article (PubMed ID: 28216422)
1. Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes.
Creasy JM; Goldman DA; Dudeja V; Lowery MA; Cercek A; Balachandran VP; Allen PJ; DeMatteo RP; Kingham TP; D'Angelica MI; Jarnagin WR
J Am Coll Surg; 2017 May; 224(5):906-916. PubMed ID: 28216422
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study).
Bergquist JR; Shah HN; Habermann EB; Hernandez MC; Ivanics T; Kendrick ML; Smoot RL; Nagorney DM; Borad MJ; McWilliams RR; Truty MJ
Int J Surg; 2018 Apr; 52():171-179. PubMed ID: 29496648
[TBL] [Abstract][Full Text] [Related]
3. "Extended" radical cholecystectomy for gallbladder cancer: long-term outcomes, indications and limitations.
Shirai Y; Sakata J; Wakai T; Ohashi T; Hatakeyama K
World J Gastroenterol; 2012 Sep; 18(34):4736-43. PubMed ID: 23002343
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Kobayashi H; Sueda T
J Gastrointest Surg; 2011 Jun; 15(6):1007-16. PubMed ID: 21547707
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial.
Goetze TO; Bechstein WO; Bankstahl US; Keck T; Königsrainer A; Lang SA; Pauligk C; Piso P; Vogel A; Al-Batran SE
BMC Cancer; 2020 Feb; 20(1):122. PubMed ID: 32059704
[TBL] [Abstract][Full Text] [Related]
6. Optimal assessment of lymph node status in gallbladder cancer.
Kim SH; Chong JU; Lim JH; Choi GH; Kang CM; Choi JS; Lee WJ; Kim KS
Eur J Surg Oncol; 2016 Feb; 42(2):205-10. PubMed ID: 26614023
[TBL] [Abstract][Full Text] [Related]
7. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
8. Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications.
Chaudhari VA; Ostwal V; Patkar S; Sahu A; Toshniwal A; Ramaswamy A; Shetty NS; Shrikhande SV; Goel M
HPB (Oxford); 2018 Sep; 20(9):841-847. PubMed ID: 29706425
[TBL] [Abstract][Full Text] [Related]
9. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer.
Jensen EH; Abraham A; Jarosek S; Habermann EB; Al-Refaie WB; Vickers SA; Virnig BA; Tuttle TM
Surgery; 2009 Oct; 146(4):706-11; discussion 711-3. PubMed ID: 19789030
[TBL] [Abstract][Full Text] [Related]
10. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.
Chijiiwa K; Nakano K; Ueda J; Noshiro H; Nagai E; Yamaguchi K; Tanaka M
J Am Coll Surg; 2001 May; 192(5):600-7. PubMed ID: 11333097
[TBL] [Abstract][Full Text] [Related]
12. Prognostic heterogeneity of the seventh edition of UICC Stage III gallbladder carcinoma: Which patients benefit from surgical resection?
Sakata J; Kobayashi T; Ohashi T; Hirose Y; Takano K; Takizawa K; Miura K; Ishikawa H; Toge K; Yuza K; Soma D; Ando T; Wakai T
Eur J Surg Oncol; 2017 Apr; 43(4):780-787. PubMed ID: 28132788
[TBL] [Abstract][Full Text] [Related]
13. Thermo-chemo-radiotherapy for advanced gallbladder carcinoma.
Kamisawa T; Tu Y; Ishiwata J; Karasawa K; Matsuda T; Sasaki T; Funata N; Tsuruta K; Okamoto A; Takahashi T
Hepatogastroenterology; 2005; 52(64):1005-10. PubMed ID: 16001617
[TBL] [Abstract][Full Text] [Related]
14. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study.
Kato A; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Kimura F; Miyazaki M
Ann Surg Oncol; 2013 Jan; 20(1):318-24. PubMed ID: 23149849
[TBL] [Abstract][Full Text] [Related]
15. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
Jarnagin WR; Ruo L; Little SA; Klimstra D; D'Angelica M; DeMatteo RP; Wagman R; Blumgart LH; Fong Y
Cancer; 2003 Oct; 98(8):1689-700. PubMed ID: 14534886
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma of the gallbladder: an appraisal of surgical resection.
Chijiiwa K; Tanaka M
Surgery; 1994 Jun; 115(6):751-6. PubMed ID: 7910985
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer.
Sirohi B; Mitra A; Jagannath P; Singh A; Ramadvar M; Kulkarni S; Goel M; Shrikhande SV
Future Oncol; 2015; 11(10):1501-9. PubMed ID: 25963427
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic spread of T2 gallbladder carcinoma: Regional lymphadenectomy is required independent of tumor location.
Toge K; Sakata J; Hirose Y; Yuza K; Ando T; Soma D; Katada T; Miura K; Takizawa K; Kobayashi T; Wakai T
Eur J Surg Oncol; 2019 Aug; 45(8):1446-1452. PubMed ID: 30962045
[TBL] [Abstract][Full Text] [Related]
19. Radical resection improves survival for patients with pT2 gallbladder carcinoma.
Wise PE; Shi YY; Washington MK; Chapman WC; Wright JK; Sharp KW; Pinson CW
Am Surg; 2001 Nov; 67(11):1041-7. PubMed ID: 11730220
[TBL] [Abstract][Full Text] [Related]
20. Trimodality therapy for advanced gallbladder cancer.
Sasson AR; Hoffman JP; Ross E; Meropol NJ; Szarka CE; Freedman G; Pinover W; Pingpank JF; Eisenberg BL
Am Surg; 2001 Mar; 67(3):277-83; discussion 284. PubMed ID: 11270889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
